Stay updated on Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.

Latest updates to the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 added and a prior site-wide notice about funding (v3.4.1) removed. These updates are administrative and do not affect the study record content or essential navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check21 days agoChange DetectedAdded a site-wide government funding notice and updated operating-status information (cc.nih.gov and opm.gov). The history now shows Revision: v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check28 days agoChange DetectedThe new version adds a 'Show glossary' option and a revision note dated 2025-10-20, with color-coded additions (green) and deletions (red) explained for the study record changes.SummaryDifference1%

- Check64 days agoChange DetectedRevision: v3.3.3 was added to the Record History; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check86 days agoChange DetectedRevision history now includes v3.3.2 and removes v3.3.1.SummaryDifference0.1%

- Check93 days agoChange DetectedDifference0.1%

Stay in the know with updates to Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.